Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics - Wikidata - awgldk - TriplyDB

Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics

Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics

http://www.wikidata.org/entity/Q28181347

about

What we know about nonsteroidal anti-inflammatory drug hypersensitivity Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies Pharmacogenomics of Prostaglandin and Leukotriene Receptors Genetic markers for differentiating aspirin-hypersensitivity Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective Genetics and pharmacogenetics of the leukotriene pathway Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.Genetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization.Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis Fatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease.Exonic variants associated with development of aspirin exacerbated respiratory diseases.Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker.Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma.Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics Contribution of the OBSCN nonsynonymous variants to aspirin exacerbated respiratory disease susceptibility in Korean population.Association Analysis Between FILIP1 Polymorphisms and Aspirin Hypersensitivity in Korean Asthmatics.Pharmacogenetics of aspirin-intolerant asthma.Update on recent advances in the management of aspirin exacerbated respiratory disease.Cysteinyl leukotriene receptors, old and new; implications for asthma.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.Montelukast, current indications and prospective future applications.Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.Genetic mechanisms in aspirin-exacerbated respiratory disease.Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics.Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study.Potential Biomarkers for NSAID-Exacerbated Respiratory Disease Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients.Putative association of SMAPIL polymorphisms with risk of aspirin intolerance in asthmatics.Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria.Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations.Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.Association analysis of ILVBL gene polymorphisms with aspirin-exacerbated respiratory disease in asthma.Physiopathology and genetics in aspirin-exacerbated respiratory disease.Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE.Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease.Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis?

P2860

Q26749250-1C6801FA-6A3B-4A08-8578-BF170FC0807D Q28067073-D76ABEA4-8C8B-44CE-82EE-B507F85AC32F Q28077789-8F6C328D-541E-43CD-BBE2-D580EE856F7B Q28195398-9DDF8C1D-5079-4B47-949A-3F2E420A0C81 Q28201262-62031ACD-C30C-467D-9813-F297868D938C Q28212087-199E3FCE-1712-4DB7-A841-3A48157EAD28 Q28254268-25709E93-45FD-4A62-91A6-A4536359E1F2 Q30396182-06641ABB-688C-4C2C-A478-24B578B88B4B Q33511377-BDF5DABF-356A-45F7-93D5-3BBC5BACC85B Q33758097-0881D754-8C11-480F-A9E0-7D6172D56F9C Q33988507-2CDA90F2-0B19-4D5B-9C97-164DC45D9DB5 Q34457070-95E7B671-70D9-4AE3-8ADA-9F5E66C4338C Q34785484-F9367C42-C872-4286-ABD0-6CE3F6634157 Q35117697-802CDD96-AF4D-43BC-A0AB-66A13843A0F4 Q35228588-25A61318-DA5B-416C-9DB9-B8BD4E9ED123 Q35859198-3C7937A6-B19B-429B-B7A4-E3E9FF74D263 Q36045148-6638574B-1346-4A3E-BF07-E5EBBC457F32 Q36485719-1901F63E-B6B9-4EA0-A189-278FC3EBE79D Q37043508-CFA99FEC-C1DE-4092-863E-1F7E865C52E6 Q37485583-0361908D-EA92-44A8-A2B4-CF34345C6660 Q38038319-E733DE5C-5BD0-41C7-A9C2-9A5FEA459CB9 Q38103710-473F834A-202F-489E-B18A-DE34F0DFCD45 Q38134073-06799578-AC46-4C27-94F7-50C0425A0A41 Q38835130-C72A9C5B-A4AF-4A52-8817-98673C529F1C Q39359391-FAAF961D-6A7B-47ED-97FC-4A2489AE9A89 Q39718340-5C7BF784-9E45-4826-A2E1-929B65C8D748 Q39811129-90758570-0B73-4B15-ACD8-9BF650DDA3F7 Q41365516-C4CA44F6-1303-4E39-9D6B-99FF9B2FF2B7 Q41500425-C17A9F63-8A56-4B39-A4B7-8002BF14199E Q41996281-049C0403-5FCC-4694-8995-8A3E3818434A Q42744363-446C4734-C643-4F90-8A74-94BABB0F95ED Q42910932-5F6EA5FF-AAC1-4B10-A145-15B266A33DF7 Q43528905-84731149-C8A6-40A5-A225-51DE3E66CC69 Q44390657-24C7B911-D98F-4FD7-B779-D17355DAC0B7 Q46034358-7A72CF79-465A-4B06-A1C9-27BE3E0D872E Q47159407-84A752D0-392C-45BA-9D38-14367C1CEB00 Q47649225-EAE0CCDD-44BC-42E1-813F-19982987AC73 Q50700053-65E7629F-68BF-4613-845B-A22AFF97115E Q51622794-957FB65F-7119-4E61-A4F4-36CBA3992C7B Q53291503-BDEBDC16-A8F2-4D2D-9E86-76A53CD0F74C

P2860

Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics

http://www.wikidata.org/entity/Q28181347

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Association analysis of cystei ...... irin intolerance in asthmatics

@ast

Association analysis of cystei ...... irin intolerance in asthmatics

@en

Association analysis of cystei ...... irin intolerance in asthmatics

@nl

type

label

Association analysis of cystei ...... irin intolerance in asthmatics

@ast

Association analysis of cystei ...... irin intolerance in asthmatics

@en

Association analysis of cystei ...... irin intolerance in asthmatics

@nl

prefLabel

Association analysis of cystei ...... irin intolerance in asthmatics

@ast

Association analysis of cystei ...... irin intolerance in asthmatics

@en

Association analysis of cystei ...... irin intolerance in asthmatics

@nl

P1433

Q28181347-C794A67C-651F-4F2F-BC4E-17C1D2825BE6

P1476

Q28181347-395F73BB-A372-4C75-9577-FB802C27EEAA

P2093

Q28181347-1152BBF4-3BA0-40FF-9999-5E716F7E8454

Q28181347-3A9FA5B0-E7C7-4F0C-8E12-5B1C321A3ECF

Q28181347-3B7E5580-123D-4306-B9EA-8C3563212DF0

Q28181347-71166E36-FEA0-415F-9DA6-EC3FC0A70DDF

Q28181347-765F2183-6BDD-46E5-8A2A-D471E2C6BBDE

Q28181347-8E9E7120-0B6C-4C0E-9591-C19B19D0B9B0

Q28181347-98DCA18E-4651-41BA-890F-7C39BE99FCB9

Q28181347-C212AC35-D61A-4E81-BF6E-A66474DDC091

Q28181347-F013B14B-5700-47C9-B5D4-22EB264FA0CE

Q28181347-F67D2497-C178-4A7B-8DC5-96A9A2E97994

P304

Q28181347-A00C4FBB-E8C9-42F9-9579-599CB27EE886

P31

Q28181347-5A6481BE-0995-4F96-BD3A-B546AFD29B0A

P3181

Q28181347-874C85DB-DB94-443B-BB92-2C07B117153F

P356

Q28181347-1738163C-BA33-43D8-BAC9-86DF54EC478B

P407

Q28181347-F1708E9A-EFFB-4079-A0BC-DA6CC8711EB7

P433

Q28181347-971D720A-6E2D-4A5A-9D65-0AD904CB517D

P478

Q28181347-6F6FEEF4-013F-4C40-AB49-F7CCD5CC7AB2

P50

Q28181347-A84A62A5-17AD-46E3-904A-117626AD2A4C

P577

Q28181347-105E4833-6A5C-4C6C-B0B7-44E63FD755F3

P5875

Q28181347-F4CB917C-BC7D-4160-97F6-56470FE1AE07

P698

Q28181347-972DFA00-40AD-41A0-A72E-6D561F35C04A

P921

Q28181347-9B3D1532-643F-4DEE-A1C8-9FB239E0317F

Q28181347-A978E61D-FCC7-4552-8471-8749DDA8EB35

P3181

P356

01.FPC.0000166456.84905.A0

P1433

Pharmacogenetics and Genomics

P1476

Association analysis of cystei ...... irin intolerance in asthmatics

@en

P2093

Byung Lae Park

http://www.w3.org/2001/XMLSchema#string

Hae-Sim Park

http://www.w3.org/2001/XMLSchema#string

Hun Soo Chang

http://www.w3.org/2001/XMLSchema#string

Hyoung Doo Shin

http://www.w3.org/2001/XMLSchema#string

Jong Sook Park

http://www.w3.org/2001/XMLSchema#string

June-Hyuk Lee

http://www.w3.org/2001/XMLSchema#string

Jung Hee Choi

http://www.w3.org/2001/XMLSchema#string

Lyoung Hyo Kim

http://www.w3.org/2001/XMLSchema#string

Yong Mok Lee

http://www.w3.org/2001/XMLSchema#string

Yoo Hyun Choi

http://www.w3.org/2001/XMLSchema#string

P304

483-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3412830

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/01.FPC.0000166456.84905.A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7772287

http://www.w3.org/2001/XMLSchema#string

P698

15970796

http://www.w3.org/2001/XMLSchema#string

P921